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Abstract
Background: This paper describes the derivation and characterization of a novel,
conditionally immortal mammary epithelial cell line named KIM-2. These cells were derived
from mid-pregnant mammary glands of a mouse harbouring one to two copies of a transgene
comprised of the ovine β-lactoglobulin milk protein gene promoter, driving expression of a
temperature-sensitive variant of simian virus-40 (SV40) large T antigen (T-Ag).
Results: KIM-2 cells have a characteristic luminal epithelial cell morphology and a stable,
nontransformed phenotype at the semipermissive temperature of 37°C. In contrast, at the
permissive temperature of 33°C the cells have an elongated spindle-like morphology and
become transformed after prolonged culture. Differentiation of KIM-2 cells at 37°C, in
response to lactogenic hormones, results in the formation of polarized dome-like structures
with tight junctions. This is accompanied by expression of the milk protein genes that
encode β-casein and whey acidic protein (WAP), and activation of the prolactin signalling
molecule, signal transducer and activator of transcription (STAT)5. Fully differentiated KIM-2
cultures at 37°C become dependent on lactogenic hormones for survival and undergo
extensive apoptosis upon hormone withdrawal, as indicated by nuclear morphology and flow
cytometric analysis. KIM-2 cells can be genetically modified by stable transfection and clonal
lines isolated that retain the characteristics of untransfected cells.
Conclusion: KIM-2 cells are a valuable addition, therefore, to currently available lines of
mammary epithelial cells. Their capacity for extensive differentiation in the absence of
exogenously added basement membrane, and ability to undergo apoptosis in response to
physiological signals will provide an invaluable model system for the study of signal
transduction pathways and transcriptional regulatory mechanisms that control differentiation
and involution in the mammary gland.
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Introduction
With each successive pregnancy, the mammary gland
completes a cycle of growth, functional differentiation and
involution. These processes are of great importance in
biology in their own right, but they also provide an example
of how proliferation, differentiation and apoptosis are
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integrated into the organization of a complex three-dimen-
sional tissue unit, whose function changes with time. The
growth and development of ductal and alveolar structures
during pregnancy is dependent on the interaction
between the epithelial cells and stromal components of
the mammary fat pad and requires the concerted actions
of both peptide and steroid hormones, and cell–cell and
cell–substratum interactions [1]. The necessity for these
complex structural and hormonal interactions provide a
challenge for the development of in vitro models for mole-
cular studies that accurately mimic the differentiation and
death of mammary epithelial cells.
A variety of mammary culture systems have been devel-
oped to facilitate studies on the regulation of gene tran-
scription in the mammary gland. Whole organ and explant
cultures have been of value in identifying the role of spe-
cific hormones in both the growth and differentiation of
mammary tissue and the induction of milk protein gene
expression [2]. These cultures have a limited lifespan,
however, and are not useful for studies at the cellular level.
Epithelial cells can be isolated from mammary tissue,
maintained in culture and induced to differentiate with lac-
togenic hormones. The use of such primary cultures has
demonstrated the importance of the cellular substratum in
the differentiation process [3]. A major drawback of this
system, in addition to the short lifespan of the cells, is the
considerable amount of starting material required.
Spontaneously immortalized cell lines have arisen from
prolonged culture of primary epithelial cells in low serum
(2%). Many of these established mammary epithelial cell
lines have proved to be useful tools in molecular and bio-
chemical studies. They include EpH4 cells [4] and the
COMMA-1D cell line, one of the most widely used in vitro
mammary systems, which exhibits mammary-specific func-
tional differentiation when exposed to lactogenic hor-
mones and extracellular matrix (ECM) [5]. Subclones of
COMMA-1D include HC11 and CID9 [6,7]. HC11 cells
have been widely used by us, and others, for studies on
transcriptional regulation of milk protein gene expression
[8,9], whereas CID9 cells have been extensively used to
demonstrate the role of ECM in milk protein gene expres-
sion [7]. Furthermore, a pure epithelial population, SCp2,
has been derived from CID9 [10]
In our laboratory, we are particularly interested in the sig-
nalling pathways that regulate gene expression in the differ-
entiating and involuting mouse mammary gland. Despite the
undoubted value of these culture systems, expression of
transgenes in vivo does not always recapitulate expression
observed in culture. This reflects the complex requirements
for mammary epithelial cell differentiation and apoptosis.
There is a need, therefore, for mammary epithelial cell lines
that more accurately mimic the developing and involuting
gland. Such cells should preferably be immortalized by a
conditional (ie reversible) mechanism (in contrast to cur-
rently available lines) and be able to be genetically modified.
In order to achieve this, we adopted a modification of the
procedure used to generate ‘immortomouse’, a line of
transgenic mice that harbour a temperature-sensitive
variant of an immortalizing gene, SV40 T-Ag, which is
expressed from a constitutive promoter H2Kb [11].
Although the ‘immortomouse’ shows thymic hyperplasia,
these transgenic mice undergo normal development and
have proven to be a useful source of material to establish
cell lines from tissues that have previously been refractory
to culturing [12]. Our attempts to establish mammary
epithelial lines from these mice were unsuccessful,
however. This may be due to insufficient levels of T-Ag
being expressed in the mammary epithelial compartment to
immortalize these cells or the presence of T-Ag in the other
mammary compartments, thereby allowing the preferential
immortalization of fibroblasts and other stromal cell types.
We therefore decided to refine this approach and target
expression of the thermolabile T-Ag mutant specifically to
the mammary epithelium of transgenic mice. Targeted
expression can be achieved using either the mouse
mammary tumour virus long terminal repeats or a milk
protein gene promoter. We chose to use the promoter of
the sheep milk protein gene encoding β-lactoglobulin
(BLG), because BLG is less dependant than WAP on the
transgene genomic integration site for its expression [13]
BLG transgenes are expressed at low levels in the
mammary glands of virgin mice, whereas expression is
regulated during pregnancy and lactation with a similar
expression profile to that of β-casein [14]. Therefore, it is
likely that BLG expression occurs in dividing cells early in
the differentiation pathway, a critical factor in establishing
cultures from early stages of mammary gland develop-
ment. Such cultures could contain epithelial stem cells
because these are known to be distributed throughout the
ductal tree [15]. We report herein the isolation and char-
acterization of a stable line of mammary epithelial cells,
named KIM-2, from mid-pregnant mammary glands of one
line of mice with a low transgene copy number. Impor-
tantly, this cell line has a phenotypically normal epithelial
morphology at 37°C and permits the analysis of the
complex processes of differentiation and apoptosis in
vitro. Moreover, we provide evidence that this line is sus-
ceptible to genetic manipulation, thus making available a
resource for analysis of genetic function.
Materials and methods
Construction of the transgene
A fusion gene, consisting of 4.2 kb of the 5′-flanking pro-
moter sequences, including the transcriptional start site, of
the ovine BLG gene [16] and the temperature-sensitive
variant of SV40 T-Ag (tsA58) coding sequences [11], was
constructed.
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The 4.2 kb SalI/EcoRV fragment of the BLG promoter was
isolated from pBJ39 (provided by Dr CBA Whitelaw) and
subcloned into pBluescript vector (Stratagene Europe,
Amsterdam, The Netherlands). A 3.9 kb BglI fragment was
isolated from pUC tsA58 [11], blunt ended using T4 DNA
polymerase and digested with BamHI, and a 2.7 kb frag-
ment containing sequences encoding large and small T-
Ag was purified. This fragment was fused to the EcoRV
site of the BLG promoter.
Generation and identification of transgenic mice
For microinjection the transgene was isolated free of
vector sequences by double digestion with SalI and XbaI,
and the transgene was purified by agarose gel elec-
trophoresis. DNA (1.5 ng/µl) was microinjected into pronu-
clear mouse eggs (collected from C57BL/6 × CBA F1
mice after mating with F1 male studs) in order to generate
transgenic mice. Lines were maintained by mating F1 mice
that harboured the transgene, as determined by poly-
merase chain reaction analysis of tail biopsies [17]. All
DNA manipulations were carried out using standard pro-
cedures [18].
DNA analysis
DNA was extracted from tail biopsies of 6-week-old mice,
and analyzed by polymerase chain reaction and Southern
blots. Genomic tail DNA was digested with an appropriate
restriction enzyme, subjected to agarose gel electrophore-
sis and transferred to nylon membrane (Hybond N; Amer-
sham Pharmacia Biotech, Uppsala, Sweden) [19].
Southern blots were hybridized [20] with a random oligo-
primed probe (Prime-It II kit; Stratagene) [21] containing
sequences from the probe 1 region of the transgene.
RNA analysis
RNA was extracted from tissue or from cultured cells
using the acid guanidium thiocyanate–phenol chloroform
method [22]. For northern blot analysis, 10 µg total RNA
was resolved on 1.0% formaldehyde agarose gels, trans-
ferred to nylon membranes (Hybond N; Amersham) and
hybridized to [32P] dCTP-labelled random primed probes.
Two probes were used for β-casein [23] and WAP [24].
Explant cultures
Mammary glands were aseptically removed from a mid-
pregnant (day 14) transgenic mouse carrying the
BLG/SV40 T-Ag construct and washed several times in
dissection medium (HEPES-buffered M199 with gen-
tamycin at 50 µg/ml and BRL’s antibiotic/antimycotic
solution; Gibco/BRL, Paisley, Scotland). The tissue was
cut with scalpels into pieces of about 1 mm thickness in
fresh dissection medium; seeded into collagen type I-
coated flasks; and cultured at either the permissive tem-
perature of 33°C or the semipermissive temperature of
37°C for about 2 weeks with daily medium changes
(1 ml/25 cm2) in serum-free F12/Dulbecco’s modified
eagle’s medium (1:1), supplemented with bovine insulin,
ovine prolactin, cortisol, oestradiol (each 5 µg/ml) and
epidermal growth factor (EGF; 10 ng/ml). During this
period, an epithelial outgrowth formed around most
explants, without fibroblast contamination. Explants were
removed by simply shaking them off and washing the
flask, and the culture was continued in F12/Dulbecco’s
modified eagle’s medium (1:1) supplemented with 10%
foetal calf serum, 5 µg/ml insulin, 10 ng/ml EGF, 5 µg/ml
linoleic acid and 5 µg/ml gentamycin.
Primary cultures were passaged after several weeks when
the circumference of the islands stopped growing. Cells
were passaged as clumps of about five to 10 cells rather
than as single cells, because this appeared to aid survival
and maintenance of the epithelial phenotype. In order to
produce clumps, trypsinization was shortened and per-
formed at room temperature, the cells scraped off with a
cell scraper, and the cell suspension handled with wide-
bore pipettes. Cells are now routinely cultured at 37°C
and passaged every three to four days at a 1:4 ratio onto
collagen-coated flasks (growth on collagen once in every
five passages is sufficient) and maintained for approxi-
mately 20 passages. No change in phenotype is observed
with careful handling.
Immunocytochemistry
Cells were grown subconfluently on collagen-coated glass
coverslips in four-well plates or on plastic slide flasks
(Nunc/Nalge Europe, Hereford, UK). The cells were fixed
in methanol:acetone for 10 min, washed with Tris-buffered
saline (TBS) pH 7.6, blocked in TBS + 20% goat serum
for 1 h, and then immunostained with a panel of primary
antibodies. Monoclonal antibodies to cytokeratin 18 and
19 were from EB Lane and SV40 T-Ag antibodies were
kindly provided by Dr DP Lane (Department of Biochem-
istry, University of Dundee, Dundee, UK). Murine smooth
muscle actin antibody was obtained from Sigma (A2547)
as were E-cadherin (U 3254), laminin (L9393) and
vimentin (V5255) (Sigma-Aldrich, Gillingham, Dorset, UK).
Rat monoclonal antibody to zonula occluden-1
(MAB1520) was from Hemicon (Chemicon International
Inc, Temecula, CA, USA). Antibody binding was visualized
with fluorescein isothiocyanate (FITC)-labelled secondary
antibodies (Sigma). Images were analyzed by fluores-
cence microscopy and, in some cases, phase and fluores-
cence images were subsequently merged.
Electron microscopy
Differentiated cells were trypsinized, centrifuged and fixed
in 3% glutaraldehyde in 0.1 mol/l sodium cacodylate/HCl
buffer of pH 7.2–7.4 at 4°C for 48 h. After washing with
distilled water (dH2O) for 20 min, the samples underwent
secondary fixation in 1% osmium tetroxide in dH2O for
45 min at room temperature. Samples were then dehy-
drated with methylated spirits and absolute ethanol,
before linking to propylene oxide for 10 min and impregna-
tion in Emix resin (Fisons, Leicester, UK) overnight at room
temperature. After polymerization for 18–24 h at 70°C,
90-nm sections were mounted on 300-mesh copper grids
and stained using the uranyl acetate/lead citrate method.
Finally, sections were examined and photographs taken
using a Jeol 100CXXII transmission electron microscope
(Jeol Ltd, Welwyn Garden City, Herts, UK).
Induction of milk protein gene expression
Cells were grown on plastic-coated or collagen-coated
flasks in growth medium until confluent. After 2 days,
hormone induction media was then added, consisting of
growth medium without EGF supplemented with dexam-
ethasone and ovine prolactin. Cultures were induced for
up to 12 days with media changes every 2 days.
Western blot analysis
In order to detect casein in total cell extracts, cells (area
8 cm2) were washed in phosphate-buffered saline and
lysed directly in 0.5 ml electrophoresis sample buffer
(0.125 mol/l Tris HCl pH 6.8, 2% sodium dodecyl sul-
phate, 2% β-2-mercaptoethanol, 10% glycerol), shearing
the DNA by repetitive pipetting, boiled for 10 min and
stored at –20°C. The protein concentrations of the
samples were determined using the BCA Protein Assay
Reagent kit (Pierce and Warriner, Chester, UK).
One dimensional sodium dodecyl sulphate-polyacrylamide
gel electrophoresis was performed as described by Laemmli
[25] in 15% polyacrylamide gels with a 3% stacking gel.
Proteins were transferred from gels to nitrocellulose filters
(Schleicher and Schuell, London, UK) at a current of
0.8mA/cm2 for 1 h using a semidry electroblotter [26]. After
blocking nonspecific binding with 1% bovine serumn
albumin in phosphate-buffered saline/Tween (0.1%), the
nitrocellulose was exposed to a polyclonal rabbit antimouse
β-casein antibody diluted 1:10000 in blocking solution.
Primary antibodies were visualized by peroxidase-conjugated
anti-Ig antibodies and ECL detection reagents (Amersham).
Electrophoretic mobility shift assays
Electrophoretic mobility shift assays were carried out using
the highest affinity STAT binding site (STM) in the BLG
promoter, as previously described [8]. Briefly, 4 µg protein
from nuclear extracts were incubated with 32P-labelled
STM oligonucleotide in binding buffer, and analyzed on 6%
native acrylamide gels, followed by autoradiography.
Acridine orange staining and fluorescence microscopy
KIM-2 cells were grown to confluency, washed in phos-
phate-buffered saline and incubated in Dulbecco’s modi-
fied eagle’s medium/F12 containing 3% serum (but no
additional growth factors) for 48 h. Cells (1 × 106) were
fixed in 70% ethanol and stained with acridine orange
(5 µg/ml; Molecular Probes Europe BV, Leiden, The
Netherlands). Classical features of apoptosis were identi-
fied with fluorescence microscopy.
Flow cytometry and annexin V assay
Undifferentiated cells
KIM-2 cells were grown as above and 24 h later cells from
the supernatant and monolayer were harvested. Cells
(1 × 105) were stained with annexin V and propidium
iodide using the Apoptosis Detection Kit and following the
manufacturer’s instructions (R&D Systems, Abingdon,
Oxford, UK). Cells were analyzed by flow cytometry using
a Coulter EPICS XL flow cytometer (Beckman Coulter,
High Wycombe, Bucks, UK). Debris and clumps were
gated out using forward and orthogonal light scatter.
Green fluorescence (525 nm; FITC annexin V) and red flu-
orescence (613 nm; propidium iodide) of 2000 cells was
measured. The experiment was repeated three times.
Differentiated cells
KIM-2 cells were differentiated for 12 days with the lacto-
genic hormones insulin, dexamethasone and prolactin.
Apoptosis was induced by removal of these hormones
and measured 17 h later, as above.
Results
Generation of β-lactoglobulin-tsA58 transgenic mice
In order to direct expression of the conditional immortaliz-
ing gene to mammary epithelium, a hybrid construct con-
taining the promoter of the sheep BLG milk protein gene,
which is expressed predominantly in ductal and alveolar
cells, was fused to the sequence encoding the tempera-
ture-sensitive early region variant of SV40 T antigen (T Ag),
tsA58. This construct (Fig. 1a) was used to generate trans-
genic mice by microinjection into fertilized oocytes from
(CBA×C57BL/6) F1 mice and in total 13 lines were gen-
erated. Several lines developed tumours in a number of
anatomical sites as a consequence of ectopic expression
of the transgene and leakiness of the temperature-sensitive
mutation at the body temperature of the mice, and eight
founders died before further analysis could be carried out.
The severity of the phenotype in the surviving lines
appeared to be copy number-related and was retained
through subsequent generations of mice. The remaining
five founders were used to derive transgenic lines. The
number of copies of the transgene in each line was deter-
mined by Southern blotting (Fig. 1b) of DNA extracted from
liver tissue and probed with a fragment of the BLG pro-
moter and ranged from one to two copies (lines 2 and 8) to
approximately 10 copies (line 13). One of the lowest copy
number lines, line SV40-2, was used for the isolation of the
KIM-2 cell line described herein. This line does not display
a tumour phenotype due to ectopic expression of T-Ag.
Expression of the transgene in simian virus 40 line 2
The level of expression of T-Ag in the mammary glands of
line SV40-2 was determined. Low levels of tsA58 T-Ag
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mRNA were detected (data not shown). Protein was ana-
lyzed by western blotting in extracts from the lactating
mammary glands of three sisters from this line (Fig. 2a).
Levels of protein were consistent within this line. Expres-
sion of T-Ag did not perturb the normal development of
the mammary gland and no mammary tumours were
observed in this, or in any of the lines, despite T-Ag being
present. This is shown in Figure 2b, which shows sections
of tissue from virgin and day 11 lactation mammary glands
of line SV40-2 and control F1 mice, showing the normal
morphology. No lactational defects were apparent and
these mice successfully nursed their offspring. This trans-
genic line has now been maintained for several years and
mammary tumours have not been observed. This contrasts
with the observation of tumour development in the
WAP-T-Ag mice. This is probably a consequence of wild-
type T-Ag being expressed in the WAP transgenics [27].
Derivation of conditionally immortal cell lines
Enrichment procedures have been described for partially
purifying epithelial cells from the other types of cells that
are present in the mammary gland [28]. These methods
use enzymatic treatment and differential centrifugation to
obtain a clean, fibroblast-free population of primary epithe-
lial cells, and did not work well in our hands with the trans-
genic mice. We therefore developed a novel, simpler
method that is based on the unpublished observation of
one of us (BB) that, on a collagen-coated surface, fibro-
blast outgrowth from mammary explants requires the pres-
ence of serum, whereas epithelial cells grow out easily in a
chemically defined medium. Initially, explant cultures were
established from mammary glands excised from several
lines of mice, with different transgene copy numbers. This
procedure was most successful with tissue from the
lowest copy number line SV40-2, and subsequent work
was carried out with mammary tissue from this line.
Mammary explant cultures were prepared by slicing the
glands into 1 mm square pieces, seeding into collagen
type I coated flasks and culturing for 2 weeks at the per-
missive (33°C) and semipermissive temperature (37°C)
until outgrowths were well established (Fig. 3a). The
explants were removed and the cells cultured until the
islands stopped expanding in size. During this time period
dome-like structures began to appear only in the cultures
grown at 37°C (Fig. 3b).
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Figure 1
BLG–tsA58 transgenic mice. (a) Scheme of vector construct; 4.2 kb
of the ovine BLG promoter including the noncoding exon 1 was fused
to the ‘enhancerless’ SV40 T-Ag temperature sensitive mutant tsA58.
The restriction sites shown are SalI (S), BamHI (B), StuI (St), and NdeI
(N). The EcoRV and BglI sites were destroyed during the construction
of this vector. (b) The transgene copy number in the five surviving
transgenic lines was estimated by Southern blotting. Digested
genomic liver DNA (10 µg) from three sisters in each of the lines was
analyzed with sheep genomic liver DNA used as a single copy control.
The blot was hybridized with probe 1, and stripped and rehybridized
with a WAP probe as a loading control.
Figure 2
Expression of T-Ag in the mammary glands of transgenic mice
harbouring one to two copies (line SV40-2) or about 10 copies (line
SV40-13) of the BLG–tsA58 transgene. (a) Protein extracts (20 µg)
were prepared from day 11 lactation mammary tissue from three age-
matched sisters from each line and a nontransgenic control mouse.
The extracts were separated by sodium dodecyl sulphate-
polyacrylamide gel electrophoresis, electroblotted onto nitrocellulose
and probed with an anti-T-Ag antibody, DP-02. The nonspecific band
is also seen in the control sample. (b) Morphological comparison of
haematoxylin and eosin stained sections of virgin and 11-day lactation
mammary glands from transgenic line SV40-2 (top) and a
nontransgenic control (bottom). Histologically, the transgenic glands
were indistinguishable from control glands. Scale bar 100 µm.
The primary cultures were routinely passaged as clumps of
five to 10 cells, because single cell passaging results in the
appearance of cells with a different morphology that was
reminiscent of a fibroblastic phenotype. These cells are
now routinely passaged every 3–4 days as clumps and
divided 1:3 or 1:4. These cells, which we have designated
KIM-2, have been maintained in culture at 37°C for over 60
passages and have a stable phenotype both on plastic and
collagen as assessed by immunocytochemistry.
Characterization of the cell line
Effects of growth temperature on morphology
T-Ag immortalizes cells by complexing with the oncosup-
pressor proteins p53 and retinoblastoma protein [29]. It
was expected that the temperature-sensitive variant of
T-Ag used to generate the transgenic animals would be
nonfunctional at 37°C. KIM-2 cells can be isolated and
grown at 37°C for over 60 passages, however, indicating
that sufficient T-Ag is functional at this temperature to
effect immortalization (Fig. 4a). In contrast, cells isolated
from mammary tissue at 33°C show an elongated spindle-
like morphology (Fig. 4b), grow rapidly and immunostain
with an antibody to a mesenchymal specific marker,
vimentin (data not shown). These cells also form colonies
in soft agar and may therefore be transformed; this is in
contrast to the cells at 37°C, which do not form colonies
(Fig. 4c and d, and Table 1). A more accurate assessment
of ability to form tumours requires growth in mice, and we
are awaiting results of injecting these cell types into
severe combined immunodeficiency mice. The tempera-
ture of 39°C is nonpermissive, and KIM-2 cells grown at
this temperature undergo a crisis and die after two or
three passages. Because KIM-2 cells are phenotypically
‘normal’ at 37°C and grow rapidly, dividing approximately
once every 24 h, we selected this growth temperature for
the experiments described in the present study, unless
otherwise indicated.
Expression of specific cell markers
The characteristics of the KIM-2 cell line were established
by immunocytochemistry. Antibody staining patterns
suggest that these cultures are highly enriched for cells of
luminal epithelial type, with over 95% of the cells staining
strongly positive for keratin 18 (Fig. 5d), a luminal cell
marker [30]. Approximately 5% of the cells stained with
either smooth muscle actin (Fig. 5c), which is characteris-
tic of myoepithelial cells, or vimentin, a stromal and fibro-
blastic marker (Fig. 5e). Most cells show nuclear staining
with a T-Ag-specific antibody (Fig. 5b). The keratin
14-specific antibody LL002 immunostains many cells. The
epitope recognized by this antibody is frequently deregu-
lated in cultured cells, however. The proportion of cells
that stain for actin remains constant, even after multiple
passages. These are probably of myoepithelial origin and
derived from KIM-2 cells that have divided to give two
types of cells (myoepithelial and luminal). This notion is
supported from observations made on clonal derivatives
(discussed below). Confluent cultures of KIM-2 cells
deposit laminin, a component of the basement membrane,
as shown by strong extracellular staining with an antibody
to laminin (Fig. 6).
Induction of differentiation
Addition of lactogenic hormones to confluent cultures of
KIM-2 cells resulted in a morphological change after
approximately 2 days. Domes appeared in the confluent
monolayer. These were substantial in size, usually contain-
ing upwards of 50 cells, and staining of these differentiated
cultures with antibodies to α-actin showed the presence of
myoepithelial cells around the domes (Fig. 7c and d). This
association of luminal and myoepithelial cells is reminiscent
of alveolar structures. Immunocytochemistry with antibod-
ies to the cell adhesion molecule E-cadherin (data not
shown) and the junction protein zonula occluden-1 (Fig. 7e
and f), which is found at the apical and lateral plasma mem-
brane boundaries between epithelial cells, showed that
tight junctions are formed between the cells. Confluent
undifferentiated monolayers of KIM-2 cells also form junc-
tions as shown by the E-cadherin staining pattern (Fig. 7a
and b). Using time lapse video microscopy, these domes
were observed to pulsate, suggesting that transepithelial
fluid transport is taking place into an expanding lumen and
confirming that tight junctions have been formed
(http://www.breast-cancer-research.com/content/2/3/v1).
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Figure 3
Derivation of primary cultures from mammary outgrowths. (a) Explants
isolated from pregnant mammary tissue from transgenic line SV40-2
developed outgrowths after 2 weeks in culture at 37°C on type I
collagen. The typical cobblestone morphology that is characteristic of
epithelial cells was observed in these outgrowths by phase contrast
microscopy. (b) After 14 days in culture the explants were removed
and the primary cultures maintained for a further 7–14 days. Dome
structures formed during this time period. Scale bar 250 µm.
The differentiation of KIM-2 cells was further investigated
using electron microscopy, which revealed the presence
of milk protein and lipid droplets within the KIM-2 cells.
Differentiated cells are polarized, microvilli being present
on the apical surface (Fig. 8a). We also observed desmo-
somes between cells (Fig. 8b).
Expression of differentiation markers
Milk protein synthesis in vivo occurs within clusters of dif-
ferentiated mammary epithelial cells in response to lacto-
genic hormones, ECM interactions and cell–cell
interactions [1]. In cultures of KIM-2 cells grown at the
semipermissive temperature of 37°C or the nonpermissive
temperature of 39°C, addition of lactogenic hormones
induced partial differentiation as assessed by the synthe-
sis of high levels of β-casein.
Figure 9a shows a western blot of induced and uninduced
late passage cells (P31) grown on tissue culture plastic.
For induction, the cells are grown to confluence, EGF
removed for 2 days, and the lactogenic hormones dexam-
ethasone, insulin and prolactin added for the time period
indicated. There appear to be at least two different forms
of cytoplasmic β-casein induced. One has an apparent
molecular mass of 29 kDa and there is also a lower molec-
ular weight band, compared with 32 kDa for the secreted
protein found in milk. The discrepancy in size is probably
due to differences in post-translational modifications
between intracellular β-casein and the secreted form, and
was also observed in HC11 mammary cells (Fig. 9a). The
level of β-casein induction is not affected by passage
number or growth on collagen (data not shown). KIM-2
cells do secrete β-casein but at very low levels.
Other milk proteins that are expressed later in pregnancy,
such as WAP, appear to require other factors in addition to
lactogenic hormones for their expression. We were inter-
ested in investigating the possibility of WAP expression in
KIM-2 cultures, because this is a more appropriate
measure of differentiation status. Figure 9b shows a time
course of WAP mRNA induction with lactogenic hormones
in KIM-2 cells grown on tissue culture plastic. Whereas β-
casein expression was induced after 2 days, WAP expres-
sion was delayed until 4–8 days after hormone stimulation.
These kinetics reflect the pattern of milk protein gene
expression in the mammary gland, in which β-casein is
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Figure 4
Effects of growth temperature on morphology
and anchorage independent growth of KIM-2.
(a) Cells isolated and grown at 37°C showing
the typical cuboidal epithelial morphology.
(b) Cells isolated and grown at 33°C have a
spindle-like mesenchymal morphology. Scale
bar for (a) and (b) 50 µm. (C) Cells, isolated
and grown at 37°C, seeded in soft agar and
cultured for 12 days. Cells do not form
colonies. (d) Cells, isolated and grown at
33°C, seeded in soft agar and cultured for 12
days at 37°C showing the formation of
colonies. Scale bar for (c) and (d) 10 µm.
Table 1
Colony formation in soft agar by ‘spindle’ and ‘normal’ KIM-2
cells
Cells seeded ‘Spindle’ KIM-2 ‘Normal’ KIM-2
2 × 104 12.6 ± 1.5 0
1 × 104 11.0 ± 2.0 0
4 × 103 9.2 ± 1.2 0
2 × 103 8.4 ± 2.0 0
1 × 103 6.4 ± 1.7 0
Cells were seeded at five different densities in soft agar and grown for
14 days. Colonies were defined as spherical growth of cells of 5 mm in
diameter or more. Values shown are the means and standard
deviations from triplicated experiments.
expressed from day 10 of pregnancy but WAP is not
expressed until approximately 4 days later. Recently a
STAT5a knockout has been generated that exhibits an
impairment of lobuloaveolar development during pregnancy
and an inability to lactate [31]. Although these mice show
normal β-casein expression, the levels of WAP expression
were reduced considerably. Clearly the induction of WAP
expression has more complex requirements that may
include contacts with the ECM, expression of specific
receptors and/or expression of differentiation-related
genes. It is possible that prolonged stimulation of KIM-2
cells with lactogenic hormones induces these changes.
Signal transduction
STAT5 is a signalling molecule for prolactin and may also
be a survival factor for differentiated mammary epithelia.
We therefore investigated the activation of STAT5 in
KIM-2 cells stimulated with prolactin. Figure 10a shows a
time-course of STAT5 induction as assayed by elec-
trophoretic mobility shift assay. Detectable amounts of
STAT5 were observed within 5 min of prolactin addition,
reaching a peak between 30 and 60 min. Interestingly, the
response to prolactin was biphasic. Following the initial
peak at 30 min, the response declined to almost basal
levels before again reaching a peak at about 24 h that was
then sustained for at least 8 days. This kinetic profile is not
surprising, because high STAT5 levels are maintained in
the mammary gland during lactation in the continued pres-
ence of prolactin. The immediate downregulation could be
in response to phosphatases, which have been shown to
be associated with cytokine receptors and may interact
directly with STAT factors [32], or to the upregulation of
other genes such as members of the suppressor of
cytokine signalling (SOCS) family of negative regulators
[33]. It will be interesting to determine the mechanism of
this early regulatory response, which is a feature of STAT
activation in other cell systems. The prolonged activation
of STAT5 could reflect the need for a survival factor for dif-
ferentiated cells and may be associated with withdrawal
from the cell cycle. Antibodies that specifically recognize
either STAT5a or STAT5b supershift the complex
observed, suggesting that both forms of STAT5 are acti-
vated in KIM-2 cells (data not shown). This parallels obser-
vations in the mammary gland [34,35].
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Figure 5
Immunocytochemical analysis of KIM-2 cells
cultures at 37°C. (a) Phase contrast. (b) The
same field showing nuclear staining with a
T-Ag-specific antibody (Pab 419). (c) Staining
with a vimentin monoclonal antibody (Vim-
13.2) was detected in some fields. (d) Strong
positive staining with a keratin 18-specific
monoclonal antibody (LE61), a luminal
epithelial marker. Scale bar for (a)–(d) 50 µm.
(e) Staining with a smooth muscle actin
monoclonal antibody, a myoepithelial marker.
(f) Positive staining with a keratin 14-specific
antibody (LL002). The epitope recognized by
this antibody is often deregulated in culture.
Scale bar for (e) and (f) 25 µm.
These characteristics suggest that KIM-2 cells are an
excellent model for mammary epithelial cell differentiation.
In order to use this model to investigate the molecular
mechanisms of signal transduction and gene expression in
mammary cells, it is essential that these cells can be
genetically modified. This has been achieved using a
variety of transfection methods to mediate DNA transfer,
although retroviral transduction is the most efficient. We
have now isolated a number of clonal cell lines from KIM-2
cells transfected with green fluorescent protein con-
structs. These clonal lines are morphologically similar to
KIM-2 cells and can be induced to form domes and differ-
entiate [36]. A similar number of cells staining for α-actin
are observed in cultures of clonal lines, suggesting that
KIM-2 cells are progenitor cells that can differentiate into
myoepithelial or luminal epithelial types. Similar observa-
tions have been made for human breast cells [37].
Induction of apoptosis in KIM-2 cells
The mammary gland undergoes a process of remodelling
after weaning in which the lobuloalveolar compartment is
removed by apoptosis. In order to investigate the molecu-
lar basis of involution, it would be invaluable to have avail-
able a mammary epithelial cell line that can be induced to
undergo apoptosis in response to physiological signals.
We therefore tested a variety of growth conditions for their
ability to induce apoptosis and found that undifferentiated
KIM-2 cells cultured in reduced serum (3%), with no
added growth factors, die over a period of 24–48 h.
Apoptosis was classically defined by the morphological
changes that occur, including cell shrinkage, chromatin
condensation and nuclear fragmentation [38]. These
changes were visualized using acridine orange staining
and fluorescence microscopy and are obvious in dying
KIM-2 cells compared with healthy cultures where the
cells have diffusely stained nuclei (Fig. 11).
Although this method allows a clear definition of apoptosis,
it does not allow rapid and precise quantification of the
process. One of the early changes that occur during apop-
tosis is the translocation of phosphatidylserine from the
inner to the outer surface of the plasma membrane, presum-
ably enabling the recognition of apoptotic cells by phago-
cytes [39]. This can be detected with annexin V and
quantified by flow cytometry. Figure 12a shows the flow
cytometric analysis of control cells and cells induced to die
24 h after treatment; the percentage of cells in each of the
four populations is shown. A small number of control cells
stain with propidium iodide and annexin V, probably as a
consequence of membrane disruption during the harvesting
procedure. An approximately eightfold increase in apoptosis
was seen when KIM-2 cells were cultured in reduced serum
with no additional growth factors. An increase in the number
of cells that stained with both propidium iodide and annexin
V was also observed, probably reflecting the late loss of
membrane integrity that occurs in cells in culture when they
are not removed by phagocytosis.
Apoptosis of differentiated KIM-2 cultures would be a
more useful model of apoptosis during involution in vivo.
We therefore induced apoptosis in differentiated KIM-2
cultures by removal of the lactogenic hormones prolactin,
dexamethasone and insulin. Approximately 30% of the
cells underwent apoptosis after 17 h in the absence of
these hormones (Fig. 12b). Control cells exhibit an appar-
ently high level of apoptosis. This is a consequence of
membrane disruption during the harvesting procedure,
because these differentiated cells are tightly associated
and difficult to disperse. Interestingly, in reduced serum
(3%) differentiated KIM-2 cells, in contrast to undifferenti-
ated cells, did not die, suggesting that at least one of the
lactogenic hormones is a survival factor for functionally dif-
ferentiated mammary epithelial cells (Fig. 12b).
Time-lapse video microscopy of differentiated cultures,
induced to die by hormone withdrawal, shows cells detach-
ing from the dish and the eventual collapse of the domes
(http://www.breast-cancer-research.com/content/2/3/v2).
The ease of inducing and quantitatively measuring apopto-
sis, coupled with the ability to manipulate KIM-2 cells
genetically, should allow a detailed analysis of the early
transcription events that regulate this process. The rele-
vance of these genes to involution in the mammary gland
can then be investigated.
Breast Cancer Research    Vol 2 No 3 Gordon et al
Figure 6
Deposition of laminin by KIM-2 cells. A confluent monolayer of
undifferentiated KIM-2 cells was stained with an antibody to laminin
and detected by FITC-conjugated secondary antibody. Control slides
with secondary antibody alone were completely blank. Scale bar
25 µm.
Discussion
The morphological changes that take place during a
mammary gland developmental cycle have been well
defined and characterized. However, the molecular mecha-
nisms that are involved in the regulation of lobuloalveolar
development during pregnancy and the removal of this
compartment by apoptosis during involution are just begin-
ning to be understood, partly because it has been difficult
to obtain a suitable in vitro model system that accurately
mimics mammary gland development. The aim of this work
was to establish a mammary cell culture system that would
be of value in biochemical and functional studies of the
control of differentiation and apoptosis.
To achieve this aim, we adapted the approach developed
by Jat et al [11] and derived a mammary-specific ‘immorto-
mouse’ using the BLG milk protein milk promoter to drive
expression of a temperature-sensitive allelle of SV40 large
T-Ag. We also developed a novel culture system to enrich
for luminal epithelial cells. These procedures allowed us to
successfully derive a novel line of conditionally immortal
mammary epithelial cells. These cells retain a stable phe-
notype that is characteristic of luminal epithelial cells at
the normal growth temperature of 37°C as evidenced by
immunocytochemical analysis using lineage specific
markers. At 39°C, the cells are not immortal and die within
a few passages.
The growth characteristics of the KIM-2 cell strain were
dramatically influenced by the culture temperature. Isolat-
ing epithelial cells at the permissive temperature of 33°C
resulted in apparently transformed cells with a spindle
morphology that form colonies in soft agar. This pheno-
type cannot be reverted by switching up the growth tem-
perature to 37°C. Switching down the growth temperature
from 37°C to 33°C, however, caused a gradual change in
morphology from cuboidal epithelial to a more fibroblastic
appearance over a period of several weeks. Immunocyto-
chemical analysis of these cells revealed the presence of
vimentin and α-actin, along with keratin 18, suggesting
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Figure 7
Analysis of junction formation and
differentiation of KIM-2 cells. (a) Phase
contrast. (b) Detection of E-cadherin on
surface of confluent monolayer of cells. Scale
bar for (a) and (b) 50 µm. (c) Phase contrast
of differentiated cells and (d) detection of
myoepithelial cell on surface of dome with an
antibody to smooth muscle α-actin. Scale bar
for (c) and (d) 50 µm. (e) Phase contrast of
dome and (f) detection of tight junctions with
antibody to zonula occluden-1. Scale bar for
(e) and (f) 25 µm.
that conversion of the epithelial cells to a more fibroblastic
or myoepithelial cell type had taken place. After a switch
down in growth temperature from 37°C to 33°C for 48 h
or more, the phenotypic switch became irreversible.
Of the 13 transgenic founder lines generated, the lowest
copy number line SV40-2 was used as the source of
mammary cells for these experiments. Surprisingly, expres-
sion of T-Ag RNA in the mammary glands of line SV40-2
mice was barely detectable by northern blot analysis (data
not shown), although T-Ag could be detected by western
blot (Fig. 2a), suggesting that the BLG promoter is dys-
regulated when fused to T-Ag sequences. The reason for
this is not clear but it may be a consequence of the inte-
gration site of the transgene and the lack of sequences
from within the body of the BLG gene and/or in its
3′-terminal end, which confer integration site indepen-
dence [40]. Whatever the mechanism, the low levels of
T-Ag messenger RNA encode sufficient protein for the
immortalizing role of SV40 T-Ag, which is readily
detectable in the nuclei of cells in culture (Fig. 5b). The
low expression of T-Ag may explain our observation that
no mammary tumours were found, even in the animals that
developed tumours at ectopic sites. Ectopic expression of
BLG transgenes has been observed previously and high
levels of T-Ag mRNA were found in the tumours.
KIM-2 cells have a characteristic epithelial morphology.
Immunocytochemical analysis demonstrated the presence
of the luminal-specific marker keratin 18 in the majority of
the cells and the absence of fibroblastic markers. Some
myoepithelial cells were observed that were characterized
by their elongated morphology and positive staining with
antibodies to α-actin. These cells were frequently found to
be associated with the dome-like structures that formed in
response to lactogenic hormone induction (Fig. 7) and may
suggest that both cell types are necessary for the formation
of these alveolar-like structures. We have derived a sub-
stantial number of clonal lines from KIM-2 cells by transfec-
tion of selectable markers. These clonal derivatives also
form dome structures and have a myoepithelial component
suggesting that KIM-2 cells are a progenitor of both luminal
and myoepithelial cells. Selective growth of these cell types
[37] would provide a resource for the discovery of genes,
using microarray technology, which are expressed specifi-
cally in one type of cell [41]. The exciting possibility that
KIM-2 cells may be stem cells will be tested by their ability
to repopulate a cleared mammary fat pad. If this is suc-
cessful, genetically modified KIM-2 cells could be used to
generate transgenic mammary glands [42].
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Figure 8
Electron microscopy of differentiated KIM-2 cells. (a) Microvilli
(arrowed) on the apical surface of cells and showing the interdigitated
cytoplasm at the boundary between two cells. Scale bar 2 µm.
(b) Higher magnification showing the presence of desmosomes
(arrowed). Scale bar 0.5 µm.
Figure 9
Analysis of the differentiation capacity of KIM-2 and HC11 cells in
response to lactogenic hormones on tissue culture plastic.
(a) Endogenous β-casein expression was analyzed in KIM-2 and HC11
cells by western blot. Total cell lysates (20 µg) were prepared from
KIM-2 cells or HC11 cells grown to confluence and induced with the
lactogenic hormone cocktail of insulin, prolactin and dexamethasone
for 4 days at 37°C. Uninduced cells were grown to confluence in
growth medium. A defatted mouse milk sample was used as a positive
control for the murine β-casein polyclonal antibody (diluted 1:10 000).
Intracellular β-casein appeared to be a doublet at approximately
29 kDa in extracts from both cell lines, whereas a 32kDa secreted
β-casein was detected in defatted milk. This size discrepancy can be
accounted for by differences in phosphorylation states between
intracellular and secreted forms of the protein. (b) WAP and β-casein
expression were analyzed in KIM-2 cells by northern blot. Total RNA
(20 µg) was prepared from KIM-2 cells grown to confluence at 37°C
and harvested or induced with lactogenic hormones for the time period
indicated. WAP mRNA was detected after 8 days exposure to
lactogenic hormones. Figures are representative of three separate
experiments, although induction of WAP expression was variable and
occurred between 4 and 8 days after hormone treatment in different
experiments.
The formation of cell–cell contacts was investigated by
using antibodies to E-cadherin and zonula occluden-1 and
by electron microscopy. Staining at cell contacts was
observed for both E-cadherin and zonula occluden-1
(Fig. 7). The formation of structures resembling desmo-
somes was seen by electron microscopy, and the pres-
ence of microvilli on the apical surfaces of cell clusters
suggests that the cells are polarized, which is a feature of
alveolar cells in vivo. The synthesis and deposition of
laminin by KIM-2 cells that we have observed may be
essential for polarization in addition to cell–cell contact.
Polarization is also essential for the expression and secre-
tion of milk proteins. We showed previously that growth
on ECM (principally laminin) is necessary for the activation
of STAT5 in response to prolactin in primary cultures [43].
It is likely, therefore, that the synthesis and deposition of
laminin by KIM-2 cells provides the necessary extracellular
signals for the activation of sufficient levels of STAT5 for
induction of full differentiation. Indeed, it has been shown
that the binding of STAT5 to the WAP promoter is essen-
tial for maximal expression [44]. It is likely that STAT5 is a
survival factor for differentiated mammary epithelial cells,
and this is currently being tested.
Undifferentiated KIM-2 cells can be induced to undergo
apoptosis by the removal of growth factors in serum.
Apoptosis is extensive and rapid with approximately 30%
of undifferentiated cells dying after 24 h. More relevantly,
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Figure 11
Induction of apoptosis in KIM-2 cells. KIM-2
cells were cultured in reduced serum and the
absence of additional growth factors for 24 h,
inducing apoptosis in approximately 40% of
the cells. (a) Control and (b) dying KIM-2
cells were stained with acridine orange and
visualized by fluorescence microscopy.
Examples of cells exhibiting classical
apoptotic morphology are indicated by the
letter 'A'.
Figure 12
Analysis of apoptosis by flow cytometry. (a) Cells were induced to
undergo apoptosis by culturing in reduced serum (3%) and the
absence of additional growth factors for 24 h. (b) Cells that had been
cultured in differentiation medium (DM) for 12 days were induced to
undergo apoptosis by removal of prolactin, insulin and dexamethasone
(AM) for 17 h. Control and dying cells were stained with annexin V and
propidium iodide (PI) and analyzed by flow cytometry. PI enters only
cells with damaged membranes (late apoptosis or necrosis). Four
populations of cells were identified: live (no stain), apoptotic (annexin V
only), late apoptotic/necrotic (annexin V + PI) and necrotic (PI) only.
The percentage of cells in each population is shown as the mean of
three experiments with the standard error of the mean.
Figure 10
Analysis of STAT5 activation by electrophoretic mobility shift assay in
KIM-2 cells stimulated with prolactin. Nuclear extracts were prepared
from confluent KIM-2 cultures stimulated with prolactin, in the absence
of EGF, for the time periods indicated. The track labelled Mamm is an
extract from a day 2 lactation mouse mammary gland. Uninduced
control cells were maintained in growth medium. Extracts (4 µg
protein) were incubated with a radioactively labelled DNA probe
containing the highest affinity ovine BLG STAT5 binding site [34] and
complexes resolved on a nondenaturing 6% acrylamide gel. A
representative of more than three experiments is shown.
apoptosis can be induced in fully differentiated KIM-2 cells
after removal of lactogenic hormones. Apoptosis has been
studied in a variety of mouse mammary epithelial cell lines.
KIM-2 cells are an important addition to this repertoire,
because they exhibit different features. Differentiated cells
do not require addition of exogenous basement membrane
for survival (unlike CID9 cells, which die with delayed
kinetics in the absence of basement membrane [45]) and
have wild-type p53 (unlike HC11 cells, which harbour
mutant p53 allelles [46]). Apoptosis in individual cells can
be observed using fluorescence microscopy, and this can
be coupled with detection of other markers such as green
fluorescent protein reporter constructs [36]. Thus, the
KIM-2 cell line will be of value in future studies on early
transcription events in the apoptotic process.
The low copy number line of BLG/SV40tsT mice can be
crossed with other mice that harbouring either transgenes
or gene deletions, thereby allowing the isolation of
mammary cell lines from interesting mouse mutants. This
will allow us to establish cell lines from knockout mice and
should be invaluable for transfection studies that are
aimed at identifying functional domains and interactions
between signalling pathways in mammary epithelium.
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